Opus GeneticsIRD

13F holders, Q2 2024 (June 30)
37holders −12
3new positions
14sold out
2famous investors
$1.53avg. 13F price*

At the end of Q2 2024, 37 institutions reported holding Opus Genetics Inc. (IRD) in their 13F filings, down 12 from Q1 2024. 3 opened new positions and 14 sold out. The largest holders were Vanguard Group Inc. ($1.5M), Geode Capital Management, LLC ($407K) and Rice Hall James & Associates, LLC ($342K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Opus Genetics Inc.
Filed as
OCUPHIRE PHARMA INC (Q2 2024)
CUSIP
67577R102
Latest filing quarter
Q2 2026

History

Number of 13F holders

050100150 Q1 2024: 49Q1 2024Q2 2024: 37Q2 2024Q3 2024: 38Q3 2024Q4 2024: 43Q4 2024Q1 2025: 46Q1 2025Q2 2025: 43Q2 2025Q3 2025: 48Q3 2025Q4 2025: 59Q4 2025Q1 2026: 79Q1 2026Q2 2026: 103Q2 2026

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions3$65K
Exits14$899K

All 13F filers, Q1 2024 → Q2 2024: 129,489 shares bought and 807,694 shares sold, net −678,205 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 37 holders

Vanguard Group Inc. 0.00% No change 992,200 $1.5M
Geode Capital Management, LLC 0.00% Add +13.4% 265,854 $407K
Rice Hall James & Associates, LLC 0.02% Reduce -23.4% 223,589 $342K
Richmond Brothers, Inc. 0.58% Reduce -15.9% 191,304 $293K
Bridgeway Capital Management, LLC 0.01% Reduce -22.0% 163,741 $251K
BlackRock Inc. 0.00% Add +10.6% 106,935 $164K
Knoll Capital Management, LLC 0.10% No change 100,000 $153K
State Street Corp. 0.00% No change 70,473 $108K
Morgan Stanley 0.00% Reduce -0.0% 56,105 $86K
Susquehanna International Group, LLP 0.00% Add +9.4% 46,577 $71K
Jane Street Group, LLC 0.00% New 42,375 $65K
Kestra Private Wealth Services, LLC 0.00% No change 42,341 $65K
Renaissance Technologies 0.00% Reduce -69.2% 41,700 $64K
Empowered Funds, LLC 0.00% Add +7.4% 39,305 $60K
Diametric Capital, LP 0.03% Reduce -26.0% 38,035 $58K
Blair William & Co. 0.00% No change 33,267 $51K
Trust Co. of Toledo NA 0.01% No change 30,963 $47K
Comerica Bank 0.00% No change 30,000 $46K
Northern Trust Corp. 0.00% Reduce -47.5% 27,267 $42K
Royal Bank of Canada 0.00% Add +438800.0% 21,945 $34K
Osaic Holdings, Inc. 0.00% Add +30.6% 21,555 $33K
Captrust Financial Advisors 0.00% No change 18,000 $28K
UBS Group AG 0.00% Add +10.4% 15,703 $24K
Bedel Financial Consulting, Inc. 0.00% No change 15,000 $23K
Citadel Advisors 0.00% Reduce -82.3% 14,098 $22K
Prelude Capital Management, LLC 0.00% Reduce -32.8% 13,852 $21K
National Bank of Canada 0.00% Add +500.0% 12,000 $19K
Stokes Family Office, LLC 0.00% No change 12,120 $19K
Tower Research Capital LLC (TRC) 0.00% Reduce -51.3% 3,592 $5K
Wells Fargo & Company 0.00% Reduce -6.0% 2,789 $4K
Simplex Trading, LLC 0.00% Reduce -37.4% 1,335 $2K
CarsonAllaria Wealth Management, Ltd. 0.00% No change 1,000 $2K
Concourse Financial Group Securities, Inc. 0.00% Reduce -38.5% 727 $1K
Bank of America Corp. 0.00% New 213 $326
Group One Trading LLC 0.00% New 76 $116
Harbour Investments, Inc. 0.00% No change 40 $61
Rhumbline Advisers 0.00% Reduce -10.3% 26 $39

"% of holder's portfolio" is IRD's weight in each manager's 13F, not the share of Opus Genetics Inc. the manager owns.